AI drug discovery

Lila Sciences Secures $235M Series A to Pioneer Autonomous AI-Driven Drug Discovery Labs

Lila Sciences, the Cambridge-based biotech innovator, has closed a $235 million Series A round, catapulting the AI-first startup to unicorn status with a $1.23 billion....